2011-5288. Change of Address; Requests for Exemption From the Bar Code Label Requirements  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; technical amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending its regulations to update the address for submitting bar code exemption requests to the Center for Drug Evaluation and Research (CDER). This action is being taken to ensure accuracy and clarity in the Agency's regulations.

    DATES:

    This rule is effective March 9, 2011.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Rikin Mehta, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 5235, Silver Spring, MD 20993-0002, 301-796-3937.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA is amending 21 CFR 201.25(d)(2) to update the address for submitting bar code exemption requests to CDER. The new address for these submissions is Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993-0002. This action is being taken to ensure accuracy and clarity in the Agency's regulations.

    Publication of this document constitutes final action on these changes under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment to the regulations provides only technical changes to update an address for submitting bar code exemption requests to CDER.

    Start List of Subjects

    List of Subjects in 21 CFR Part 201

    • Drugs
    • Labeling
    • Reporting and recordkeeping requirements
    End List of Subjects

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 201 is amended as follows:

    Start Part

    PART 201—LABELING

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 201 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 355, 358, 360, 360b, 360gg-360ss, 371, 374, 379e; 42 U.S.C. 216, 241, 262, 264.

    End Authority Start Amendment Part

    2. Section 201.25 is amended by revising paragraph (d)(2) to read as follows:

    End Amendment Part
    Bar code label requirements.
    * * * * *

    (d) * * *

    (2) Requests for an exemption should be sent to the Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993-0002 (requests involving a drug product) or to the Office of Compliance and Biologics Quality (HFM-600), Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852 (requests involving a biological product).

    Start Signature

    Dated: March 3, 2011.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2011-5288 Filed 3-8-11; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Effective Date:
3/9/2011
Published:
03/09/2011
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
2011-5288
Dates:
This rule is effective March 9, 2011.
Pages:
12847-12847 (1 pages)
Docket Numbers:
Docket No. FDA-2011-N-0101
Topics:
Drugs, Labeling, Reporting and recordkeeping requirements
PDF File:
2011-5288.pdf
CFR: (1)
21 CFR 201.25